![PDF) Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal ® Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil PDF) Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal ® Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil](https://i1.rgstatic.net/publication/334184453_Pharmacokinetics_and_safety_of_deltoid_or_gluteal_injection_of_aripiprazole_lauroxil_NanoCrystal_R_Dispersion_used_for_initiation_of_the_long-acting_antipsychotic_aripiprazole_lauroxil/links/5d1c244d92851cf440602666/largepreview.png)
PDF) Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal ® Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil
![PDF] Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics | Semantic Scholar PDF] Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9971933d7b6c167361ab8cd829680d1cbf9cc46b/2-Figure1-1.png)
PDF] Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics | Semantic Scholar
![Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | Advances in Therapy Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | Advances in Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12325-020-01566-w/MediaObjects/12325_2020_1566_Figa_HTML.png)
Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | Advances in Therapy
![Pharmaceuticals | Free Full-Text | Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders Pharmaceuticals | Free Full-Text | Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-16-00603/article_deploy/html/images/pharmaceuticals-16-00603-g001-550.jpg)
Pharmaceuticals | Free Full-Text | Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders
![Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms | Pharmacological Reports Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms | Pharmacological Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs43440-022-00440-6/MediaObjects/43440_2022_440_Fig1_HTML.png)
Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms | Pharmacological Reports
![1) Aripiprazole acts as a functional antagonist where dopamine levels... | Download Scientific Diagram 1) Aripiprazole acts as a functional antagonist where dopamine levels... | Download Scientific Diagram](https://www.researchgate.net/publication/49677845/figure/fig6/AS:601673340825645@1520461511801/1-Aripiprazole-acts-as-a-functional-antagonist-where-dopamine-levels-are-high-2.png)
1) Aripiprazole acts as a functional antagonist where dopamine levels... | Download Scientific Diagram
![Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study - ScienceDirect Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0920996413003411-gr1.jpg)